U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557680) titled 'Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients' on Jan. 05.
Brief Summary: This randomized control trial, which was carried out at Sindh Institute of Urology and Transplantation (SIUT), used a non-probability consecutive sampling technique for six months from January 1, 2025, to June 30, 2025.
Study Start Date: Jan. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Hypertension
Hemodynamic Response
Anesthesia
Intervention:
DRUG: Dexmedetomidine
Dexmedetomidine (0.5 mcg/kg) diluted in 20 mLs of normal saline was administered intravenously using a syringe pump over 10 m...